Evidence map›Paper›PMID 28301299›Full record

ArticleSmall GTPases2019

Differential role for PAK1 and PAK4 during the invadopodia lifecycle.

Nicole S Nicholas, Aikaterini Pipili, Michaela S Lesjak, Claire M Wells

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Small GTPases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Decoding Rho GTPase signalling networks in directed cell migration.Frontiers in cell and developmental biology · 2026
    Review
  2. Article
  3. Rho family GTPase signaling through type II p21-activated kinases.Cellular and molecular life sciences : CMLS · 2022
    Review
  4. Review
  5. The extracellular matrix in tumor progression and metastasis.Clinical & experimental metastasis · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Nicole S Nicholasa Division of Cancer Studies , New Hunts House, Guy's Campus, King's College London , London , UK.
Aikaterini Pipilia Division of Cancer Studies , New Hunts House, Guy's Campus, King's College London , London , UK.
Michaela S Lesjaka Division of Cancer Studies , New Hunts House, Guy's Campus, King's College London , London , UK.
Claire M Wellsa Division of Cancer Studies , New Hunts House, Guy's Campus, King's College London , London , UK.
King's College London · GBNational Institute for Health Research · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PAK1 and PAK4 are members of the p-21 activated kinase family of serine/threonine kinases. PAK1 has previously been implicated in both the formation and disassembly of invasive cell protrusions, termed invadopodia. We recently reported a novel role for PAK4 during invadopodia maturation and confirmed a specific role for PAK1 in invadopodia formation; findings we will review here. Moreover, we found that PAK4 induction of maturation is delivered via interaction with the RhoA regulator PDZ-RhoGEF. We can now reveal that loss of PAK4 expression leads to changes in invadopodia dynamics. Ultimately we propose that PAK4 but not PAK1 is a key mediator of RhoA activity and provide further evidence that modulation of PAK4 expression levels leads to changes in RhoA activity.

Indexed as

Cell LineHumansMelanomaNeoplasm Invasivenessp21-Activated KinasesPodosomesrhoA GTP-Binding ProteinRho Guanine Nucleotide Exchange FactorsARHGEF11 protein, humanp21-Activated KinasesPAK1 protein, humanPAK4 protein, humanrhoA GTP-Binding ProteinRHOA protein, humanRho Guanine Nucleotide Exchange FactorsinvadopodiaPAKRhoA

Identifiers

PMID28301299
PMCPMC6548287
OpenAlexW2597079027

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.